Navigation Links
Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results
Date:2/17/2012

ISELIN, N.J., Feb. 17, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today reported financial results for the fourth quarter and twelve-month period ended December 31, 2011. These results are included in the Company's Yearly Report on Form 10-K which has been filed with the SEC.

Fourth Quarter Ended December 31, 2011The Company recorded a net loss of $0.4 million, or $0.01 per share, for the fourth quarter 2011 compared to a net loss of $0.2 million, or $0.00 per share, in the fourth quarter 2010.  

During the quarter, the Company paid for some preliminary administrative costs to prepare for the start of a proof-of-concept trial in Gout patients using Levotofisopam in January of 2012. In connection with this trial the Company also incurred consulting fees and costs for the completion of a non-human primate toxicology study. The Company continued to spend for G&A on a conservative basis.

Gross research and development expenses were $198,992 compared to $117,771 in 2010. The Company received a $244,479 cash grant in 2010 under the Federal Qualifying Therapeutic Discovery Project related to the Dextofisopam program and this was shown as a credit to gross R&D in 2010, resulting in a net R&D credit of $126,708. The majority of the increased spending in 2011 was for clinical study fees as the Company paid for preliminary administrative fees for the proof-of-concept Gout trial that commenced in January of 2012 at Duke University.

General and administrative expenses for the fourth quarter of 2011 decreased by $44,409, or 18%, from $251,593 in 2010 to $207,184 in 2011. The primary reductions were a $26,000 reduction in salaries and benefits and an $18,000 reduction in various other areas. The decrease in payroll costs in 2011 reflects lower stock compensation costs and the elimination of an administrative position in 2010.  There was also a reduction of various facility related expenses.

At December
'/>"/>

SOURCE Pharmos Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmos Corporation Reports 2011 Second Quarter Results
2. Pharmos Corporation Reports 2010 Third Quarter Results
3. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
4. Pharmos Corporation Reports 2009 Third Quarter Results
5. Pharmos Issues Business Update on Dextofisopam Trial and Financing
6. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
7. Angeion Corporation to Report First Quarter Fiscal 2012 Financial Results on Tuesday, February 28, 2012
8. Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure
9. Unilife Corporation Announces Financial Results for Fiscal Year 2012 Second Quarter
10. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
11. Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... For the first time, cardiac surgeons, medical ... the SynCardia temporary Total Artificial Heart in a peer ... the Journal of Visualized Experiments website. ... the SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... the SynCardia Total Artificial Heart," a July 18, 2014 ...
(Date:7/31/2014)... , July 31, 2014 The Galien Foundation ... Prix Galien USA Awards. The ... accolade and recognizes the technical, scientific and clinical research ... This year brings the highest number of nominees ... USA . Nominees include biomedical products across three ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... Verisk Health announced that it ... include greater predictive power and reporting capabilities. The product is ... of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) system. ... department (ED) utilization and measure practice variation for both commercial ...
... Oct. 17, 2011 The Radiosurgery Society™ (RSS), a ... science and clinical practice of stereotactic body radiotherapy (SBRT) ... February 23-25 at the La Costa Resort in Carlsbad, ... the newly-named Radiosurgery Society has been expanded to serve ...
Cached Medicine Technology:Verisk Health's DxCG Risk Solutions Technology Ready to Support Industry Adoption of ICD-10-CM 2Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 2Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 3
(Date:7/31/2014)... NEWwoodworks, fine woodworking group at New Energy ... a website dedicated to highlighting their craft and their ... handcrafted cabinetry, furniture, stairs , doors, and other ... for taking on the remarkable, challenging projects that few ... reclaimed wood, often using near extinct species such as ...
(Date:7/31/2014)... 31, 2014 Dr. Mohebi was asked ... love the experience of traveling and sharing what we ... Southern California. We are now witnessing results that ... It is our pleasure to communicate this knowledge to ... efficient ways of performing FUE transplantation helped inspire many ...
(Date:7/31/2014)... Andrie, Inc. V. Dept. of Treasury, Mich. ... Court has made the determination that a purchaser of tangible ... taxpayer was unable to prove during an audit that ... the Court of Appeals decision on whether a purchaser bears ... for purchases from Michigan sellers. The Court states “in order ...
(Date:7/31/2014)... NY (PRWEB) July 31, 2014 Located on ... street from Macy’s, The Rothenberg Law Firm LLP has moved ... Seventh Avenue. , The Rothenberg Law Firm has been handling ... has been spurred by growth in the firm’s continued success ... The firm’s New York office has a team of experienced ...
(Date:7/31/2014)... 31, 2014 Two years in the ... in-depth overview of the research behind the latest scientific ... Davis and Vesanto Melina, well-respected authorities on plant-based nutrition, ... are safe and adequate for people at all stages ... as athletes and pregnant or lactating women. , ...
Breaking Medicine News(10 mins):Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3
... LaVoie Group, a full-service,provider of public relations, ... science clients, today announced that it has,been selected ... therapeutics,company, Neotropix(R), Inc., Donna L. LaVoie, President ... to represent Neotropix during an important stage in ...
... dental clinic of Dr. Michael McCarty, is now offering ... is the answer for those who need dental work ... procedures have made it safe and comfortable for people ... memories of a painful experience. Dr. Michael McCarty from ...
... A protein required for the earliest steps in embryonic development ... the brains of adult animals, scientists have revealed. An ... beta-catenin could be a potential target for drugs to enhance ... are published online this week and appear in the October ...
... MATEO, Calif., Sept. 27 In order to ... of Labor Ray Marshall, the outside,hearing officer in ... announced that he will be issuing a notice ... were unable to,conclude their presentations over the original ...
... allergy and asthma problems after Hurricane Ike and provides helpful tips ... ... TX (PRWEB) September 24, 2008--Although Hurricane Ike has already wreaked havoc ... devastating hurricane has yet to be determined. It may be ...
... Whole Health Educators Form Army in the Battle Against Chronic Disease ... ... -- Can overeating be a symptom of negative emotions? Could a ... diet or anxiety? Yes, says an international organization whose uniquely trained ...
Cached Medicine News:Health News:LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster 2Health News:Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry -- All Gain, No Pain 2Health News:'Hub' of fear memory formation identified in brain cells 2Health News:'Hub' of fear memory formation identified in brain cells 3Health News:Hearing Officer Secretary Ray Marshall to Set Additional Date(s) for United Healthcare Workers-West Trusteeship Hearing 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 3Health News:Growing Health Profession Could Unlock Key to a Healthier America 2Health News:Growing Health Profession Could Unlock Key to a Healthier America 3Health News:Growing Health Profession Could Unlock Key to a Healthier America 4
For the quantitative determination of apolipoprotein B (apo B) in serum and plasma....
For the quantitative in vitro determination of Urea in serum, plasma or urine....
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: